Abstract
Fibrinogen is a large glycoprotein, synthesized primarily in the liver. With a normal plasma concentration of 1.5–3.5 g/L, fibrinogen is the most abundant blood coagulation factor. The final stage of blood clot formation is the conversion of soluble fibrinogen to insoluble fibrin, the polymeric scaffold for blood clots that stop bleeding (a protective reaction called hemostasis) or obstruct blood vessels (pathological thrombosis). Fibrin is a viscoelastic polymer and the structural and mechanical properties of the fibrin scaffold determine its effectiveness in hemostasis and the development and outcome of thrombotic complications. Fibrin polymerization comprises a number of consecutive reactions, each affecting the ultimate 3D porous network structure. The physical properties of fibrin clots are determined by structural features at the individual fibrin molecule, fibrin fiber, network, and whole clot levels and are among the most important functional characteristics, enabling the blood clot to withstand arterial blood flow, platelet-driven clot contraction, and other dynamic forces. This chapter describes the molecular structure of fibrinogen, the conversion of fibrinogen to fibrin, the mechanical properties of fibrin as well as its structural origins and lastly provides evidence for the role of altered fibrin clot properties in both thrombosis and bleeding.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allan P, Uitte de Willige S, Abou-Saleh RH, Connell SD, Ariens RA (2012) Evidence that fibrinogen gamma’ directly interferes with protofibril growth: implications for fibrin structure and clot stiffness. J Thromb Haemost 10(6):1072–1080. https://doi.org/10.1111/j.1538-7836.2012.04717.x
Altieri DC, Agbanyo FR, Plescia J, Ginsberg MH, Edgington TS, Plow EF (1990) A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). J Biol Chem 265(21):12119–12122
Ariens RA (2013) Fibrin(ogen) and thrombotic disease. J Thromb Haemost 11(Suppl 1):294–305. https://doi.org/10.1111/jth.12229
Blombäck B, Hessel B, Hogg D, Therkildsen L (1978) A two-step fibrinogen–fibrin transition in blood coagulation. Nature 275(5680):501–505. https://doi.org/10.1038/275501a0
Bolliger D, Seeberger MD, Tanaka KA (2012) Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev 26(1):1–13. https://doi.org/10.1016/j.tmrv.2011.07.005
Borissoff JI, Spronk HM, ten Cate H (2011) The hemostatic system as a modulator of atherosclerosis. N Engl J Med 364(18):1746–1760. https://doi.org/10.1056/NEJMra1011670
Bowley SR, Okumura N, Lord ST (2009) Impaired protofibril formation in fibrinogen gamma N308K is due to altered D: D and “A:a” interactions. Biochemistry 48(36):8656–8663. https://doi.org/10.1021/bi900239b
Bridge KI, Philippou H, Ariens R (2014) Clot properties and cardiovascular disease. Thromb Haemost 112(5):901–908. https://doi.org/10.1160/th14-02-0184
Britton S, Kim O, Pancaldi F, Xu Z, Litvinov RI, Weisel JW, Alber M (2019) Contribution of nascent cohesive fiber-fiber interactions to the non-linear elasticity of fibrin networks under tensile load. Acta Biomater 94:514–523. https://doi.org/10.1016/j.actbio.2019.05.068
Brown JH, Volkmann N, Jun G, Henschen-Edman AH, Cohen C (2000) The crystal structure of modified bovine fibrinogen. Proc Natl Acad Sci USA 97(1):85–90. https://doi.org/10.1073/pnas.97.1.85
Brown AE, Litvinov RI, Discher DE, Purohit PK, Weisel JW (2009) Multiscale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of water. Science 325(5941):741–744. https://doi.org/10.1126/science.1172484
Brown AC, Baker SR, Douglas AM, Keating M, Alvarez-Elizondo MB, Botvinick EL, Guthold M, Barker TH (2015) Molecular interference of fibrin’s divalent polymerization mechanism enables modulation of multiscale material properties. Biomaterials 49:27–36. https://doi.org/10.1016/j.biomaterials.2015.01.010
Caracciolo G, De Spirito M, Castellano AC, Pozzi D, Amiconi G, De Pascalis A, Caminiti R, Arcovito G (2003) Protofibrils within fibrin fibres are packed together in a regular array. Thromb Haemost 89(4):632–636
Casini A, Undas A, Palla R, Thachil J, de Moerloose P (2018) Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH. J Thromb Haemost 16(9):1887–1890. https://doi.org/10.1111/jth.14216
Cawthern KM, van ‘t Veer C, Lock JB, DiLorenzo ME, Branda RF, Mann KG (1998) Blood coagulation in hemophilia A and hemophilia C. Blood 91(12):4581–4593
Celinska-Lowenhoff M, Zabczyk M, Iwaniec T, Plens K, Musial J, Undas A (2018) Reduced plasma fibrin clot permeability is associated with recurrent thromboembolic events in patients with antiphospholipid syndrome. Rheumatology (Oxford) 57(8):1340–1349. https://doi.org/10.1093/rheumatology/key089
Chen F, Qiao Q, Xu P, Fan B, Chen Z (2014) Effect of factor XIII-A Val34Leu polymorphism on myocardial infarction risk: a meta-analysis. Clin Appl Thromb Hemost 20(8):783–792. https://doi.org/10.1177/1076029613504130
Chernysh IN, Weisel JW (2008) Dynamic imaging of fibrin network formation correlated with other measures of polymerization. Blood 111(10):4854–4861. https://doi.org/10.1182/blood-2007-08-105247
Chernysh IN, Nagaswami C, Weisel JW (2011) Visualization and identification of the structures formed during early stages of fibrin polymerization. Blood 117(17):4609–4614. https://doi.org/10.1182/blood-2010-07-297671
Chernysh IN, Nagaswami C, Peshkova AD, Kosolapova S, Cuker A, Cines DB, Cambor CL, Litvinov RI, Weisel JW (2020) The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli. Sci Rep 10(1):5112. https://doi.org/10.1038/s41598-020-59526-x
Chung DW, Davie EW (1984) Gamma and gamma’ chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry 23(18):4232–4236. https://doi.org/10.1021/bi00313a033
Cieslik J, Mrozinska S, Broniatowska E, Undas A (2018) Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study. Blood 131(7):797–807. https://doi.org/10.1182/blood-2017-07-798306
Cohen C, Parry DA (1990) Alpha-helical coiled coils and bundles: how to design an alpha-helical protein. Proteins 7(1):1–15. https://doi.org/10.1002/prot.340070102
Collet JP, Montalescot G, Lesty C, Weisel JW (2002) A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circ Res 90(4):428–434. https://doi.org/10.1161/hh0402.105095
Collet J-P, Moen JL, Veklich YI, Gorkun OV, Lord ST, Montalescot G, Weisel JW (2005) The αC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. Blood 106(12):3824–3830. https://doi.org/10.1182/blood-2005-05-2150
Collet JP, Allali Y, Lesty C, Tanguy ML, Silvain J, Ankri A, Blanchet B, Dumaine R, Gianetti J, Payot L, Weisel JW, Montalescot G (2006) Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 26(11):2567–2573. https://doi.org/10.1161/01.ATV.0000241589.52950.4c
De Vries JJ, Snoek CJM, Rijken DC, De Maat MPM (2020) Effects of post-translational modifications of fibrinogen on clot formation, clot structure, and fibrinolysis. Arterioscler Thromb Vasc Biol 40 (in press). https://doi.org/10.1161/atvbaha.119.313626
Domingues MM, Macrae FL, Duval C, McPherson HR, Bridge KI, Ajjan RA, Ridger VC, Connell SD, Philippou H, Ariens RA (2016) Thrombin and fibrinogen gamma’ impact clot structure by marked effects on intrafibrillar structure and protofibril packing. Blood 127(4):487–495. https://doi.org/10.1182/blood-2015-06-652214
Doolittle RF, Pandi L (2006) Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. Biochemistry 45(8):2657–2667. https://doi.org/10.1021/bi0524767
Duval C, Profumo A, Aprile A, Salis A, Millo E, Damonte G, Gauer JS, Ariëns RAS, Rocco M (2020) Fibrinogen αC-regions are not directly involved in fibrin polymerization as evidenced by a “Double-Detroit” recombinant fibrinogen mutant and knobs-mimic peptides. J Thromb Haemost 18(4):802–814. https://doi.org/10.1111/jth.14725
Erickson HP, Fowler WE (1983) Electron microscopy of fibrinogen, its plasmic fragments and small polymers. Ann N Y Acad Sci 408:146–163. https://doi.org/10.1111/j.1749-6632.1983.tb23242.x
Everse SJ, Spraggon G, Doolittle RF (1998a) A three-dimensional consideration of variant human fibrinogens. Thromb Haemost 80(1):1–9
Everse SJ, Spraggon G, Veerapandian L, Riley M, Doolittle RF (1998b) Crystal structure of fragment double-D from human fibrin with two different bound ligands. Biochemistry 37(24):8637–8642. https://doi.org/10.1021/bi9804129
Falvo MR, Millard D, O’Brien ET 3rd, Superfine R, Lord ST (2008) Length of tandem repeats in fibrin’s alphaC region correlates with fiber extensibility. J Thromb Haemost 6(11):1991–1993. https://doi.org/10.1111/j.1538-7836.2008.03147.x
Flick MJ, Du X, Witte DP, Jirouskova M, Soloviev DA, Busuttil SJ, Plow EF, Degen JL (2004) Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 113(11):1596–1606. https://doi.org/10.1172/jci20741
Fogelson AL, Keener JP (2010) Toward an understanding of fibrin branching structure. Phys Rev E: Stat, Nonlin, Soft Matter Phys 81(5):051922. https://doi.org/10.1103/PhysRevE.81.051922
Fowler WE, Erickson HP (1979) Trinodular structure of fibrinogen. Confirmation by both shadowing and negative stain electron microscopy. J Mol Biol 134(2):241–249. https://doi.org/10.1016/0022-2836(79)90034-2
Galanakis DK (1993) Inherited dysfibrinogenemia: emerging abnormal structure associations with pathologic and nonpathologic dysfunctions. Semin Thromb Hemost 19(4):386–395. https://doi.org/10.1055/s-2007-993290
Galanakis DK, Henschen A, Peerschke EI, Kehl M (1989) Fibrinogen Stony Brook, a heterozygous A alpha 16Arg—Cys dysfibrinogenemia. Evaluation of diminished platelet aggregation support and of enhanced inhibition of fibrin assembly. J Clin Invest 84(1):295–304. https://doi.org/10.1172/jci114154
Galanakis D, Spitzer S, Scharrer I (1993) Unusual A alpha 16Arg– > Cys dysfibrinogenaemic family: absence of normal A alpha-chains in fibrinogen from two of four heterozygous siblings. Blood Coagul Fibrinolysis 4(1):67–71
Ganter MT, Hofer CK (2008) Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 106(5):1366–1375. https://doi.org/10.1213/ane.0b013e318168b367
Gersh KC, Nagaswami C, Weisel JW (2009a) Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. Thromb Haemost 102(6):1169–1175. https://doi.org/10.1160/th09-03-0199
Gersh KC, Nagaswami C, Weisel JW, Lord ST (2009b) The presence of gamma’ chain impairs fibrin polymerization. Thromb Res 124(3):356–363. https://doi.org/10.1016/j.thromres.2008.11.016
Guthold M, Liu W, Sparks EA, Jawerth LM, Peng L, Falvo M, Superfine R, Hantgan RR, Lord ST (2007) A comparison of the mechanical and structural properties of fibrin fibers with other protein fibers. Cell Biochem Biophys 49(3):165–181. https://doi.org/10.1007/s12013-007-9001-4
Hall CE, Slayter HS (1959) The fibrinogen molecule: its size, shape, and mode of polymerization. J Biophys Biochem Cytol 5(1):11–16. https://doi.org/10.1083/jcb.5.1.11
Hanss M, Biot F (2001) A database for human fibrinogen variants. Ann N Y Acad Sci 936:89–90. https://doi.org/10.1111/j.1749-6632.2001.tb03495.x
He S, Blomback M, Jacobsson Ekman G, Hedner U (2003) The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. J Thromb Haemost 1(6):1215–1219. https://doi.org/10.1046/j.1538-7836.2003.00242.x
Henschen A, McDonagh J (1986) Chapter 7 fibrinogen, fibrin and factor XIII. In: Neuberger A, van Deenen LLM (eds) New comprehensive biochemistry, vol 13. Elsevier, pp 171–241. https://doi.org/10.1016/s0167-7306(08)60053-8
Hirota-Kawadobora M, Terasawa F, Yonekawa O, Sahara N, Shimizu E, Okumura N, Katsuyama T, Shigematsu H (2003) Fibrinogens Kosai and Ogasa: Bβ15Gly → Cys (GGT → TGT) substitution associated with impairment of fibrinopeptide B release and lateral aggregation. J Thromb Haemost 1(2):275–283. https://doi.org/10.1046/j.1538-7836.2003.00052.x
Hudson NE, Houser JR, O’Brien ET, Taylor RM, Superfine R, Lord ST, Falvo MR (2010) Stiffening of individual fibrin fibers equitably distributes strain and strengthens networks. Biophys J 98(8):1632–1640. https://doi.org/10.1016/j.bpj.2009.12.4312
Hudson NE, Ding F, Bucay I, O’Brien ET, Gorkun OV, Superfine R, Lord ST, Dokholyan NV, Falvo MR (2013) Submillisecond elastic recoil reveals molecular origins of fibrin fiber mechanics. Biophys J 104(12):2671–2680. https://doi.org/10.1016/j.bpj.2013.04.052
Hugenholtz GC, Macrae F, Adelmeijer J, Dulfer S, Porte RJ, Lisman T, Ariens RA (2016) Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen. J Thromb Haemost 14(5):1054–1066. https://doi.org/10.1111/jth.13278
Janmey PA, Amis EJ, Ferry JD (1983) Rheology of fibrin clots. VI. Stress relaxation, creep, and differential dynamic modulus of fine clots in large shearing deformations. J Rheol 27(2):135–153. https://doi.org/10.1122/1.549722
Jansen KA, Zhmurov A, Vos BE, Portale G, Merino DH, Litvinov RI, Tutwiler V, Kurniawan NA, Bras W, Weisel JW, Barsegov V, Koenderink GH (2020) Molecular packing structure of fibrin fibers resolved by X-ray scattering and molecular modeling. Soft Matter 16:8272–8283. https://doi.org/10.1039/d0sm00916d
Kang H, Wen Q, Janmey PA, Tang JX, Conti E, MacKintosh FC (2009) Nonlinear elasticity of stiff filament networks: strain stiffening, negative normal stress, and filament alignment in fibrin gels. J Phys Chem B 113(12):3799–3805. https://doi.org/10.1021/jp807749f
Kattula S, Byrnes JR, Wolberg AS (2017) Fibrinogen and fibrin in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 37(3):e13–e21. https://doi.org/10.1161/atvbaha.117.308564
Kim OV, Litvinov RI, Weisel JW, Alber MS (2014) Structural basis for the nonlinear mechanics of fibrin networks under compression. Biomaterials 35(25):6739–6749. https://doi.org/10.1016/j.biomaterials.2014.04.056
Kim OV, Liang X, Litvinov RI, Weisel JW, Alber MS, Purohit PK (2016) Foam-like compression behavior of fibrin networks. Biomech Model Mechanobiol 15(1):213–228. https://doi.org/10.1007/s10237-015-0683-z
Klykov O, van der Zwaan C, Heck AJR, Meijer AB, Scheltema RA (2020) Missing regions within the molecular architecture of human fibrin clots structurally resolved by XL-MS and integrative structural modeling. Proc Natl Acad Sci U S A 117(4):1976–1987. https://doi.org/10.1073/pnas.1911785117
Köhler S, Schmid F, Settanni G (2015) The internal dynamics of fibrinogen and its implications for coagulation and adsorption. PLoS Comput Biol 11(9):e1004346–e1004346. https://doi.org/10.1371/journal.pcbi.1004346
Kollman JM, Pandi L, Sawaya MR, Riley M, Doolittle RF (2009) Crystal structure of human fibrinogen. Biochemistry 48(18):3877–3886. https://doi.org/10.1021/bi802205g
Kostelansky MS, Betts L, Gorkun OV, Lord ST (2002) 2.8 A crystal structures of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the “b” site disrupts its nearby calcium-binding site. Biochemistry 41(40):12124–12132. https://doi.org/10.1021/bi0261894
Langer BG, Weisel JW, Dinauer PA, Nagaswami C, Bell WR (1988) Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem 263(29):15056–15063
Leong L, Chernysh IN, Xu Y, Sim D, Nagaswami C, de Lange Z, Kosolapova S, Cuker A, Kauser K, Weisel JW (2017) Clot stability as a determinant of effective factor VIII replacement in hemophilia A. Res Pract Thromb Haemost 1(2):231–241. https://doi.org/10.1002/rth2.12034
Lepedda AJ, Cigliano A, Cherchi GM, Spirito R, Maggioni M, Carta F, Turrini F, Edelstein C, Scanu AM, Formato M (2009) A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. Atherosclerosis 203(1):112–118. https://doi.org/10.1016/j.atherosclerosis.2008.07.001
Li W, Sigley J, Pieters M, Helms CC, Nagaswami C, Weisel JW, Guthold M (2016) Fibrin fiber stiffness is strongly affected by fiber diameter, but not by fibrinogen glycation. Biophys J 110(6):1400–1410. https://doi.org/10.1016/j.bpj.2016.02.021
Li W, Sigley J, Baker SR, Helms CC, Kinney MT, Pieters M, Brubaker PH, Cubcciotti R, Guthold M (2017) Nonuniform internal structure of fibrin fibers: Protein density and bond density strongly decrease with increasing diameter. Biomed Res Int 2017:6385628–6385628. https://doi.org/10.1155/2017/6385628
Liang X, Chernysh I, Purohit PK, Weisel JW (2017) Phase transitions during compression and decompression of clots from platelet-poor plasma, platelet-rich plasma and whole blood. Acta Biomater 60:275–290. https://doi.org/10.1016/j.actbio.2017.07.011
Lisman T, Ariens RA (2016) Alterations in fibrin structure in patients with liver diseases. Semin Thromb Hemost 42(4):389–396. https://doi.org/10.1055/s-0036-1572327
Litvinov RI, Weisel JW (2016) What is the biological and clinical relevance of fibrin? Semin Thromb Hemost 42(4):333–343. https://doi.org/10.1055/s-0036-1571342
Litvinov RI, Gorkun OV, Owen SF, Shuman H, Weisel JW (2005) Polymerization of fibrin: specificity, strength, and stability of knob-hole interactions studied at the single-molecule level. Blood 106(9):2944–2951. https://doi.org/10.1182/blood-2005-05-2039
Litvinov RI, Gorkun OV, Galanakis DK, Yakovlev S, Medved L, Shuman H, Weisel JW (2006) Polymerization of fibrin: direct observation and quantification of individual B:b knob-hole interactions. Blood 109(1):130–138. https://doi.org/10.1182/blood-2006-07-033910
Litvinov RI, Yakovlev S, Tsurupa G, Gorkun OV, Medved L, Weisel JW (2007) Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other. Biochemistry 46(31):9133–9142. https://doi.org/10.1021/bi700944j
Litvinov RI, Faizullin DA, Zuev YF, Weisel JW (2012) The α-helix to β-sheet transition in stretched and compressed hydrated fibrin clots. Biophys J 103(5):1020–1027. https://doi.org/10.1016/j.bpj.2012.07.046
Litvinov RI, Kononova O, Zhmurov A, Marx KA, Barsegov V, Thirumalai D, Weisel JW (2018) Regulatory element in fibrin triggers tension-activated transition from catch to slip bonds. Proc Natl Acad Sci U S A 115(34):8575–8580. https://doi.org/10.1073/pnas.1802576115
Litvinov RI, Nabiullina RM, Zubairova LD, Shakurova MA, Andrianova IA, Weisel JW (2019) Lytic susceptibility, structure, and mechanical properties of fibrin in systemic lupus erythematosus. Front Immunol 10:1626. https://doi.org/10.3389/fimmu.2019.01626
Liu W, Jawerth LM, Sparks EA, Falvo MR, Hantgan RR, Superfine R, Lord ST, Guthold M (2006) Fibrin fibers have extraordinary extensibility and elasticity. Science 313(5787):634. https://doi.org/10.1126/science.1127317
Liu W, Carlisle CR, Sparks EA, Guthold M (2010) The mechanical properties of single fibrin fibers. J Thromb Haemost 8(5):1030–1036. https://doi.org/10.1111/j.1538-7836.2010.03745.x
Longstaff C, Varju I, Sotonyi P, Szabo L, Krumrey M, Hoell A, Bota A, Varga Z, Komorowicz E, Kolev K (2013) Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones. J Biol Chem 288(10):6946–6956. https://doi.org/10.1074/jbc.M112.404301
Luddington RJ (2005) Thrombelastography/thromboelastometry. Clin Lab Haematol 27(2):81–90. https://doi.org/10.1111/j.1365-2257.2005.00681.x
Macrae FL, Domingues MM, Casini A, Ariens RA (2016) The (patho)physiology of fibrinogen gamma’. Semin Thromb Hemost 42(4):344–355. https://doi.org/10.1055/s-0036-1572353
Madrazo J, Brown JH, Litvinovich S, Dominguez R, Yakovlev S, Medved L, Cohen C (2001) Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-A resolution. Proc Natl Acad Sci USA 98(21):11967–11972. https://doi.org/10.1073/pnas.211439798
Marchi RC, Carvajal Z, Boyer-Neumann C, Anglés-Cano E, Weisel JW (2006) Functional characterization of fibrinogen Bicêtre II: a gamma 308 Asn– > Lys mutation located near the fibrin D: D interaction sites. Blood Coagul Fibrinolysis 17(3):193–201. https://doi.org/10.1097/01.mbc.0000220241.22714.68
Marsh JJ, Guan HS, Li S, Chiles PG, Tran D, Morris TA (2013) Structural insights into fibrinogen dynamics using amide hydrogen/deuterium exchange mass spectrometry. Biochemistry 52(32):5491–5502. https://doi.org/10.1021/bi4007995
Matsuka YV, Medved LV, Migliorini MM, Ingham KC (1996) Factor XIIIa-catalyzed cross-Linking of recombinant αC fragments of human fibrinogen. Biochemistry 35(18):5810–5816. https://doi.org/10.1021/bi952294k
Medved L, Weisel JW (2009) Recommendations for nomenclature on fibrinogen and fibrin. J Thromb Haemost 7(2):355–359. https://doi.org/10.1111/j.1538-7836.2008.03242.x
Medved L, Ugarova T, Veklich Y, Lukinova N, Weisel J (1990) Electron microscope investigation of the early stages of fibrin assembly. Twisted protofibrils and fibers. J Mol Biol 216(3):503–509. https://doi.org/10.1016/0022-2836(90)90376-w
Mills JD, Ariens RA, Mansfield MW, Grant PJ (2002) Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. Circulation 106(15):1938–1942. https://doi.org/10.1161/01.cir.0000033221.73082.06
Missori M, Papi M, Maulucci G, Arcovito G, Boumis G, Bellelli A, Amiconi G, De Spirito M (2010) Cl—and F—anions regulate the architecture of protofibrils in fibrin gel. Eur Biophys J 39(6):1001–1006. https://doi.org/10.1007/s00249-009-0492-3
Mosesson MW, Finlayson JS, Umfleet RA (1972) Human fibrinogen heterogeneities. 3. Identification of chain variants. J Biol Chem 247(16):5223–5227
Mosesson MW, DiOrio JP, Siebenlist KR, Wall JS, Hainfeld JF (1993) Evidence for a second type of fibril branch point in fibrin polymer networks, the trimolecular junction. Blood 82(5):1517–1521
Mrozinska S, Cieslik J, Broniatowska E, Malinowski KP, Undas A (2019) Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism. J Thromb Haemost 17(11):1912–1922. https://doi.org/10.1111/jth.14579
Mullin JL, Gorkun OV, Lord ST (2000) Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism. Biochemistry 39(32):9843–9849. https://doi.org/10.1021/bi000045c
O’Brien ET, Falvo MR, Millard D, Eastwood B, Taylor RM, Superfine R (2008) Ultrathin self-assembled fibrin sheets. Proc Natl Acad Sci U S A 105(49):19438–19443. https://doi.org/10.1073/pnas.0804865105
Okumura N, Gorkun OV, Lord ST (1997) Severely impaired polymerization of recombinant fibrinogen gamma-364 Asp – > His, the substitution discovered in a heterozygous individual. J Biol Chem 272(47):29596–29601. https://doi.org/10.1074/jbc.272.47.29596
Okumura N, Terasawa F, Hirota-Kawadobora M, Yamauchi K, Nakanishi K, Shiga S, Ichiyama S, Saito M, Kawai M, Nakahata T (2006) A novel variant fibrinogen, deletion of Bβ111Ser in coiled-coil region, affecting fibrin lateral aggregation. Clin Chim Acta 365(1):160–167. https://doi.org/10.1016/j.cca.2005.08.014
Okumura N, Terasawa F, Haneishi A, Fujihara N, Hirota-Kawadobora M, Yamauchi K, Ota H, Lord ST (2007) B:b interactions are essential for polymerization of variant fibrinogens with impaired holes ‘a’1. J Thromb Haemost 5(12):2352–2359. https://doi.org/10.1111/j.1538-7836.2007.02793.x
Palka I, Nessler J, Nessler B, Piwowarska W, Tracz W, Undas A (2010) Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism. Heart 96(14):1114–1118. https://doi.org/10.1136/hrt.2010.192740
Piechocka IK, Bacabac RG, Potters M, Mackintosh FC, Koenderink GH (2010) Structural hierarchy governs fibrin gel mechanics. Biophys J 98(10):2281–2289. https://doi.org/10.1016/j.bpj.2010.01.040
Pieters M, Wolberg AS (2019) Fibrinogen and fibrin: An illustrated review. Res Pract Thromb Haemost 3(2):161–172. https://doi.org/10.1002/rth2.12191
Ping L, Huang L, Cardinali B, Profumo A, Gorkun OV, Lord ST (2011) Substitution of the human αC region with the analogous chicken domain generates a fibrinogen with severely impaired lateral aggregation: fibrin monomers assemble into protofibrils but protofibrils do not assemble into fibers. Biochemistry 50(42):9066–9075. https://doi.org/10.1021/bi201094v
Protopopova AD, Barinov NA, Zavyalova EG, Kopylov AM, Sergienko VI, Klinov DV (2015) Visualization of fibrinogen αC regions and their arrangement during fibrin network formation by high-resolution AFM. J Thromb Haemost 13(4):570–579. https://doi.org/10.1111/jth.12785
Protopopova AD, Litvinov RI, Galanakis DK, Nagaswami C, Barinov NA, Mukhitov AR, Klinov DV, Weisel JW (2017) Morphometric characterization of fibrinogen’s αC regions and their role in fibrin self-assembly and molecular organization. Nanoscale 9(36):13707–13716. https://doi.org/10.1039/c7nr04413e
Purohit PK, Litvinov RI, Brown AEX, Discher DE, Weisel JW (2011) Protein unfolding accounts for the unusual mechanical behavior of fibrin networks. Acta Biomater 7(6):2374–2383. https://doi.org/10.1016/j.actbio.2011.02.026
Riha P, Wang X, Liao R, Stoltz JF (1999) Elasticity and fracture strain of whole blood clots. Clin Hemorheol Microcirc 21(1):45–49
Rocco M, Molteni M, Ponassi M, Giachi G, Frediani M, Koutsioubas A, Profumo A, Trevarin D, Cardinali B, Vachette P, Ferri F, Pérez J (2014) A comprehensive mechanism of fibrin network formation involving early branching and delayed single-to double-strand transition from coupled time-resolved X-ray/light-scattering detection. J Am Chem Soc 136(14):5376–5384. https://doi.org/10.1021/ja5002955
Ryan EA, Mockros LF, Weisel JW, Lorand L (1999) Structural origins of fibrin clot rheology. Biophys J 77(5):2813–2826. https://doi.org/10.1016/S0006-3495(99)77113-4
Scott EM, Ariens RA, Grant PJ (2004) Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol 24(9):1558–1566. https://doi.org/10.1161/01.ATV.0000136649.83297.bf
Spraggon G, Everse SJ, Doolittle RF (1997) Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389(6650):455–462. https://doi.org/10.1038/38947
Standeven KF, Carter AM, Grant PJ, Weisel JW, Chernysh I, Masova L, Lord ST, Ariëns RAS (2007) Functional analysis of fibrin γ-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness. Blood 110(3):902–907. https://doi.org/10.1182/blood-2007-01-066837
Storm C, Pastore JJ, MacKintosh FC, Lubensky TC, Janmey PA (2005) Nonlinear elasticity in biological gels. Nature 435(7039):191–194. https://doi.org/10.1038/nature03521
Sumaya W, Wallentin L, James SK, Siegbahn A, Gabrysch K, Bertilsson M, Himmelmann A, Ajjan RA, Storey RF (2018) Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy. Eur Heart J 39(13):1078–1085. https://doi.org/10.1093/eurheartj/ehy013
Torbet J, Freyssinet JM, Hudry-Clergeon G (1981) Oriented fibrin gels formed by polymerization in strong magnetic fields. Nature 289(5793):91–93. https://doi.org/10.1038/289091a0
Trezzini C, Jungi TW, Kuhnert P, Peterhans E (1988) Fibrinogen association with human monocytes: evidence for constitutive expression of fibrinogen receptors and for involvement of Mac-1 (CD18, CR3) in the binding. Biochem Biophys Res Commun 156(1):477–484. https://doi.org/10.1016/s0006-291x(88)80866-0
Tsurupa G, Mahid A, Veklich Y, Weisel JW, Medved L (2011) Structure, stability, and interaction of fibrin αC-domain polymers. Biochemistry 50(37):8028–8037. https://doi.org/10.1021/bi2008189
Undas A (2016) How to assess fibrinogen levels and fibrin clot properties in clinical practice? Semin Thromb Hemost 42(4):381–388. https://doi.org/10.1055/s-0036-1579636
Undas A, Ariens RA (2011) Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol 31(12):e88–99. https://doi.org/10.1161/atvbaha.111.230631
Undas A, Szuldrzynski K, Stepien E, Zalewski J, Godlewski J, Tracz W, Pasowicz M, Zmudka K (2008) Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress. Atherosclerosis 196(2):551–557. https://doi.org/10.1016/j.atherosclerosis.2007.05.028
Undas A, Slowik A, Wolkow P, Szczudlik A, Tracz W (2010) Fibrin clot properties in acute ischemic stroke: relation to neurological deficit. Thromb Res 125(4):357–361. https://doi.org/10.1016/j.thromres.2009.11.013
Veklich YI, Gorkun OV, Medved LV, Nieuwenhuizen W, Weisel JW (1993) Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated alpha C fragments on polymerization. J Biol Chem 268(18):13577–13585
Vos BE, Martinez-Torres C, Burla F, Weisel JW, Koenderink GH (2020) Revealing the molecular origins of fibrin’s elastomeric properties by in situ X-ray scattering. Acta Biomater 104:39–52. https://doi.org/10.1016/j.actbio.2020.01.002
Weisel JW (1986) The electron microscope band pattern of human fibrin: various stains, lateral order, and carbohydrate localization. J Ultrastruct Mol Struct Res 96(1–3):176–188. https://doi.org/10.1016/0889-1605(86)90019-4
Weisel JW (2004) The mechanical properties of fibrin for basic scientists and clinicians. Biophys Chem 112(2–3):267–276. https://doi.org/10.1016/j.bpc.2004.07.029
Weisel JW, Litvinov RI (2013) Mechanisms of fibrin polymerization and clinical implications. Blood 121(10):1712–1719. https://doi.org/10.1182/blood-2012-09-306639
Weisel JW, Litvinov RI (2017) Fibrin formation, structure and properties. Sub-cellular biochemistry 82:405–456. https://doi.org/10.1007/978-3-319-49674-0_13
Weisel JW, Medved L (2001) The structure and function of the alpha C domains of fibrinogen. Ann NY Acad Sci 936:312–327. https://doi.org/10.1111/j.1749-6632.2001.tb03517.x
Weisel JW, Warren SG, Cohen C (1978) Crystals of modified fibrinogen: size, shape and packing of molecules. J Mol Biol 126(2):159–183. https://doi.org/10.1016/0022-2836(78)90357-1
Weisel JW, Phillips GN Jr, Cohen C (1983) The structure of fibrinogen and fibrin: II. Architecture of the fibrin clot. Ann N Y Acad Sci 408:367–379. https://doi.org/10.1111/j.1749-6632.1983.tb23257.x
Weisel JW, Stauffacher CV, Bullitt E, Cohen C (1985) A model for fibrinogen: domains and sequence. Science 230(4732):1388–1391. https://doi.org/10.1126/science.4071058
White NJ (2018) Clot structure predicts recurrent thrombosis. Blood 131(7):715–716. https://doi.org/10.1182/blood-2018-01-824169
Williams RC (1981) Morphology of bovine fibrinogen monomers and fibrin oligomers. J Mol Biol 150(3):399–408. https://doi.org/10.1016/0022-2836(81)90555-6
Wolberg AS, Allen GA, Monroe DM, Hedner U, Roberts HR, Hoffman M (2005) High dose factor VIIa improves clot structure and stability in a model of haemophilia B. Br J Haematol 131(5):645–655. https://doi.org/10.1111/j.1365-2141.2005.05820.x
Wolfenstein-Todel C, Mosesson MW (1981) Carboxy-terminal amino acid sequence of a human fibrinogen gamma-chain variant (gamma’). Biochemistry 20(21):6146–6149. https://doi.org/10.1021/bi00524a036
Yang Z, Mochalkin I, Doolittle RF (2000) A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. Proc Natl Acad Sci U S A 97(26):14156–14161. https://doi.org/10.1073/pnas.97.26.14156
Yee VC, Pratt KP, Côté HC, Trong IL, Chung DW, Davie EW, Stenkamp RE, Teller DC (1997) Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen. Structure 5(1):125–138. https://doi.org/10.1016/s0969-2126(97)00171-8
Yermolenko IS, Lishko VK, Ugarova TP, Magonov SN (2011) High-resolution visualization of fibrinogen molecules and fibrin fibers with atomic force microscopy. Biomacromol 12(2):370–379. https://doi.org/10.1021/bm101122g
Yeromonahos C, Polack B, Caton F (2010) Nanostructure of the fibrin clot. Biophys J 99(7):2018–2027. https://doi.org/10.1016/j.bpj.2010.04.059
Zhmurov A, Brown AE, Litvinov RI, Dima RI, Weisel JW, Barsegov V (2011) Mechanism of fibrin(ogen) forced unfolding. Structure 19(11):1615–1624. https://doi.org/10.1016/j.str.2011.08.013
Zhmurov A, Protopopova AD, Litvinov RI, Zhukov P, Mukhitov AR, Weisel JW, Barsegov V (2016) Structural basis of interfacial flexibility in fibrin oligomers. Structure 24(11):1907–1917. https://doi.org/10.1016/j.str.2016.08.009
Zhmurov A, Protopopova AD, Litvinov RI, Zhukov P, Weisel JW, Barsegov V (2018) Atomic structural models of fibrin oligomers. Structure 26(6):857–868.e854. https://doi.org/10.1016/j.str.2018.04.005
Zucker M, Seligsohn U, Salomon O, Wolberg AS (2014) Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost 12(7):1121–1130. https://doi.org/10.1111/jth.12600
Zuev YF, Litvinov RI, Sitnitsky AE, Idiyatullin BZ, Bakirova DR, Galanakis DK, Zhmurov A, Barsegov V, Weisel JW (2017) Conformational flexibility and self-association of fibrinogen in concentrated solutions. J Phys Chem B 121(33):7833–7843. https://doi.org/10.1021/acs.jpcb.7b05654
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Litvinov, R.I., Pieters, M., de Lange-Loots, Z., Weisel, J.W. (2021). Fibrinogen and Fibrin. In: Harris, J.R., Marles-Wright, J. (eds) Macromolecular Protein Complexes III: Structure and Function. Subcellular Biochemistry, vol 96. Springer, Cham. https://doi.org/10.1007/978-3-030-58971-4_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-58971-4_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58970-7
Online ISBN: 978-3-030-58971-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)